<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McMurray</surname>
    <given-names>J. J. V.</given-names>
   </name>
   <name>
    <surname>Solomon</surname>
    <given-names>S. D.</given-names>
   </name>
   <name>
    <surname>Inzucchi</surname>
    <given-names>S. E.</given-names>
   </name>
   <name>
    <surname>Køber</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kosiborod</surname>
    <given-names>M. N.</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>F. A.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction</article-title>. 
  <source>N. Engl. J. Med.</source>
  <volume>381</volume> (
  <issue>21</issue>), 
  <fpage>1995</fpage>–
  <lpage>2008</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1911303</pub-id>
  <pub-id pub-id-type="pmid">31535829</pub-id>
 </mixed-citation>
</ref>
